Catalyst Pharmaceuticals (CPRX) – New Coverage
-
Citi Starts Catalyst Pharmaceutical Partners (CPRX) at Buy
-
BofA Securities Starts Catalyst Pharmaceutical Partners (CPRX) at Buy, 'undervalued biotech with key drug launch this year'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CPRX Stock Lookup